Evolent Health (EVH) Accounts Payables (2015 - 2026)

Evolent Health has reported Accounts Payables for 12 years, with the latest figure at $63.0 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 8.98% year-over-year to $63.0 million; the trailing twelve-month figure through Mar 2026 stood at $63.0 million (up 8.98% YoY), and the FY2025 full-year result was $59.8 million, down 37.75% from the prior year.
• Accounts Payables for Q1 2026 stood at $63.0 million, up from $59.8 million in the prior quarter.
• The five-year high for Accounts Payables was $96.6 million in Q2 2022, with the low at $39.0 million in Q2 2024.
• Average Accounts Payables over 5 years is $64.3 million, with a median of $61.9 million recorded in 2022.
• Year-over-year, Accounts Payables jumped 142.14% in 2022 and tumbled 49.28% in 2024.
• Tracing EVH's Accounts Payables over 5 years: stood at $57.2 million in 2022, then fell by 15.62% to $48.2 million in 2023, then surged by 99.03% to $96.0 million in 2024, then plunged by 37.75% to $59.8 million in 2025, then advanced by 5.41% to $63.0 million in 2026.
• The last three Accounts Payables figures came in at $63.0 million (Q1 2026), $59.8 million (Q4 2025), and $72.2 million (Q3 2025), per Business Quant data.

Peer Comparison